Yaxin Zhang

Mrs. Yaxin Zhang

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
GWGuangdong Wang
Guangdong Wang
YZYaxin Zhang
Yaxin Zhang
In the article “Comparison of rhythm and rate control medications for new-onset atrial fibrillation in septic patients: MIMIC-IV database analysis”, Weng et al. used ICD-9/ICD-10 codes to define sepsis. However, we suggest that using the Sepsis-3.0 criteria, which incorporates SOFA scoring and infection evidence, would provide a more accurate diagnosis. The MIMIC-IV database offers a derived table based on Sepsis-3.0, which could improve cohort definition and enhance the study’s clinical relevance. We recommend that future research adopt Sepsis-3.0 or perform sensitivity analyses to improve result robustness.

4 June 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
JXJia Xu
Jia Xu
GWGuangdong Wang
Guangdong Wang
XCXinran Chen
Xinran Chen
XXXinyi Xu
Xinyi Xu
YWYun Wang
Yun Wang
YZYaxin Zhang
Yaxin Zhang
Background: Intracerebral hemorrhage (ICH) remains a devastating cerebrovascular condition, marked by high fatality and limited availability of prognostic tools. The red blood cell distribution width-to-albumin ratio (RAR) has recently gained attention as a composite biomarker of systemic inflammation and nutritional condition, but its prognostic value in ICH remains unclear. We aim to examine how RAR relates to mortality risk among individuals with ICH.Methods: We performed a retrospective cohort analysis using the Medical Information Mart for Intensive Care-IV database. A total of 1,410 ICH individuals hospitalized in the intensive care unit were included and categorized into quartiles according to their RAR levels. The primary endpoint was all-cause mortality at 365 days, while 90-day all-cause mortality served as a secondary endpoint. Kaplan–Meier survival analysis, time-varying Cox regression model, and restricted cubic spline analyses (RCS)analysis were performed to assess the link between RAR and mortality risk. The predictive utility of RAR was further assessed through receiver operating characteristic (ROC)curve. Subgroup analyses explored potential effect modifications.Results: Among the 1,410 ICH patients analyzed, the median age was 69 years. The all-cause mortality rates at 90-day and 365-day were 35.53 and 42.62%, respectively. Individuals with the highest RAR levels experienced significantly greater 90 days (54.34% vs. 21.97%, p < 0.001) and 365 days (62.18% vs. 29.77%, p < 0.001) than those with the lowest levels. Time-varying Cox regression model revealed that increased RAR levels were significantly and independently linked to greater mortality risk (hazard ratios [HR] for 365-day mortality:1.07, 95% CI:1.02–1.13, p = 0.005; HR for 90-day mortality: 1.14, 95%CI: 1.05–1.12, p = 0.001). ROC curve analysis demonstrated that combining RAR with the SOFA score improved predictive accuracy for 90-day and 365-day. RCS analyses indicated a nonlinear connection between higher RAR values and mortality rates. Subgroup analyses revealed that a largely uniform effect of RAR across different subpopulations except for age, gender, and race.Conclusion: An elevated RAR is independently and significantly associated with increased all-cause mortality in ICH patients, regardless of established risk predictors. Its combination with the SOFA score enhances prognostic accuracy. These results suggest its potential clinical utility for early risk stratification.

28 October 2025 in Scientific Reports
Verified
Journal Article
Open access
YGYuanshuo Ge
Yuanshuo Ge
GWGuangdong Wang
Guangdong Wang
YHYun Huang
Yun Huang
YZYaxin Zhang
Yaxin Zhang
The hemoglobin glycation index (HGI) is a promising marker for assessing glycemic control and outcomes in critically ill patients, but its prognostic value in Trauma/Surgical Intensive Care Units (TSICU/SICU) remains unclear. This study investigates the predictive value of HGI in relation to mortality. This retrospective analysis used data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, a publicly available critical care database, focusing on TSICU/SICU patients. HGI was calculated as the difference between observed and predicted HbA1c levels. Associations between HGI quartiles and 28-day and 360-day mortality were assessed using Kaplan-Meier survival analysis, multivariate Cox regression, and restricted cubic spline (RCS) models. A stacked ensemble machine learning model validated HGI's predictive power, and mediation analysis evaluated sodium as a mediator. Kaplan-Meier analysis showed significant survival differences across HGI quartiles (log-rank p < 0.001), with the lowest quartile demonstrating the worst outcomes. Cox regression revealed that higher HGI was independently associated with lower 28-day and 360-day mortality (HR 0.76, 95% CI 0.72-0.81, p < 0.001). ROC analysis confirmed HGI outperformed HbA1c and glucose in predictive performance. The stacked ensemble model achieved an AUC of 0.85, highlighting HGI's predictive strength. Mediation analysis found sodium mediated only 3.1% of HGI's total effect on 28-day mortality, suggesting direct mechanisms. HGI is a robust predictor of short- and long-term mortality in TSICU/SICU patients, surpassing traditional glycemic markers. Incorporating HGI into risk stratification models could improve patient management, and further studies are needed to validate its clinical utility and explore underlying mechanisms.

12 August 2025 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
YGYuanshuo Ge
Yuanshuo Ge
GWGuangdong Wang
Guangdong Wang
TLTingting Liu
Tingting Liu
WJWenwen Ji
Wenwen Ji
JSJiaolin Sun
Jiaolin Sun
YZYaxin Zhang
Yaxin Zhang
Asthma-related mortality in the intensive care unit (ICU) remains poorly characterized, with no existing predictive models specifically designed for this high-risk population. This study aimed to develop and externally validate a machine learning-based model to predict 30-day in-hospital mortality among ICU patients with asthma. The model was developed using data from MIMIC-IV 2.2 and externally validated on a subset of MIMIC-IV 3.1. Clinical variables from the first 24 h of ICU admission were extracted. Feature selection was conducted using both LASSO regression and the Boruta algorithm. Seven machine learning algorithms were trained and evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis. The best-performing model was identified based on internal and external validation results. SHapley Additive exPlanations (SHAP) were employed to interpret feature importance. The final model was deployed as an interactive web-based tool. A total of 4385 ICU asthma patients were analyzed. The final XGBoost model, using 12 features, achieved the highest AUROC in both internal (0.83) and external (0.80) validation, and demonstrated the best calibration and net clinical benefit. SHAP analysis identified age, respiratory rate, RDW, urine output, and anion gap as top predictors. The model outperformed conventional ICU scores and is available as a web-based tool. We developed and externally validated a robust prediction model for 30-day mortality in ICU patients with asthma. The model offers strong performance, interpretability, and clinical utility, supporting its use for real-time risk stratification and decision-making in critical care settings.

17 July 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
YGYuanshuo Ge
Yuanshuo Ge
GWGuangdong Wang
Guangdong Wang
YHYun Huang
Yun Huang
YZYaxin Zhang
Yaxin Zhang
Background: Glycemic variability (GV), typically quantified by the coefficient of variation (CV) and the root mean square of successive differences (rMSSD), has been recognized as a potential predictor of poor outcomes in critically ill patients. However, its prognostic value in neurosurgical populations remains unclear. This study investigated the association between postoperative GV and mortality following craniotomy.Methods: We retrospectively analyzed 1,969 adult ICU patients who underwent cranial surgery. GV was measured using both CV and rMSSD calculated from blood glucose values during the ICU stay. The primary outcome was 28-day all-cause mortality; the secondary outcome was 90-day mortality. Multivariable Cox regression, restricted cubic splines, threshold effect analysis, and mediation analysis via blood urea nitrogen (BUN) were conducted. A Random Survival Forest (RSF) model was developed using machine learning and interpreted with SHAP values.Results: Higher GV, as reflected by both elevated CV and rMSSD, was independently associated with increased 28-day and 90-day mortality (CV per 10-unit HR: 1.20; rMSSD per 10-unit HR: 1.02; all P < 0.01). BUN partially mediated the association between GV and mortality. GV outperformed traditional clinical scores (SOFA, GCS, CCI) in ROC analysis (CV AUC = 0.72). The RSF model achieved an AUC of 0.841 and identified GV metrics as top predictors.Conclusions: Postoperative glycemic variability, assessed by CV and rMSSD, is an independent and modifiable predictor of short- and mid-term mortality following craniotomy. These findings highlight the clinical importance of GV in postoperative risk stratification and support its integration into neurosurgical critical care.

24 February 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HZHuan Zuo
Huan Zuo
XZXin Zuo
Xin Zuo
YZYaxin Zhang
Yaxin Zhang
WZWeihong Zheng
Weihong Zheng
Background: Abnormal glucose regulation is common in critically ill patients with intracerebral hemorrhage (ICH), but the prognostic relevance of early glucose patterns remains unclear. We aimed to identify early blood glucose trajectories in ICU patients with ICH and evaluate their association with short-term mortality. Methods: Adult patients with ICH were identified from the MIMIC-IV database. Latent class analysis was applied to blood glucose measurements obtained within the first 36 hours after ICU admission to identify distinct glucose trajectory classes. Cox proportional hazards models were used to assess the association between glucose trajectories and 28-day in-hospital mortality with multivariable adjustment. A 36-hour landmark analysis and sensitivity analyses including patients with ICU length of stay <36 hours were conducted to evaluate robustness. Results: A total of 1,978 patients were classified into three glucose trajectory classes: stable normoglycemia, a U-shaped pattern with initial severe hyperglycemia, and an inverted U-shaped pattern with marked glycemic fluctuation. Compared with the stable group, both unfavorable trajectory classes were associated with significantly higher 28-day in-hospital mortality after full adjustment ( P < 0.05). These associations were consistent across landmark and sensitivity analyses. Kaplan–Meier analyses demonstrated significant survival differences among trajectory classes, and subgroup analyses suggested effect modification by age and diabetes status. Conclusions: Early blood glucose trajectories within the first 36 hours after ICU admission are independently associated with 28-day in-hospital mortality in patients with ICH. Dynamic glucose patterns may provide additional prognostic value for early risk stratification.